Dr. Reddy’s Laboratories has informed that the Company has allotted 6,475 equity shares of Re 1 each of the Company, fully paid up, on September 15, 2025, to eligible employees pursuant to exercise of their Stock Options under Dr. Reddy’s Employees ADR Stock Options Scheme, 2007. Further, the company has enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The above information is a part of company’s filings submitted to BSE.
